Document:

Ex-4.2

 

Exhibit 4.2

     First Supplemental Indenture (this “Supplemental Indenture”), dated as of August  ,
2007, among COVENTRY HEALTH CARE, INC., a Delaware corporation (the “Company”), and Union
Bank of California, N.A., a national banking association duly organized and existing under
the laws of the United States of America, as trustee with respect to the series of
Securities specified below under the Indenture referred to below (the “New Trustee”).

WITNESSETH:

          WHEREAS, the Company has heretofore entered into an Indenture, dated as of March 20, 2007 (the
“Indenture”), with The Bank of New York, as trustee (the “Initial Trustee”), providing for the
issuance of Securities of the Company;

          WHEREAS, Section 301 of the Indenture permits the Company to appoint as trustee for any series
of Securities a Person other than the Initial Trustee, and Section 901 of the Indenture
contemplates such appointment shall be evidenced by a Supplemental Indenture;

          WHEREAS, the Company desires to appoint the New Trustee, and the New Trustee desires to accept
the appointment, to act as Trustee under the Indenture with respect
to the Company’s      % Senior Notes
due 2014 (the “Notes”); and

          WHEREAS, all things necessary to make this Supplemental Indenture a valid and legally binding
agreement of the Company have been done.

          NOW THEREFORE, in consideration of the foregoing and for other good and valuable
consideration, the receipt of which is hereby acknowledged, the Company, and the New Trustee
mutually covenant and agree as follows:

ARTICLE I

AMENDMENTS TO THE INDENTURE

          1. Appointment of Trustee with respect to the Notes. The Company hereby appoints the
New Trustee, and the New Trustee hereby accepts its appointment, as the Trustee under the Indenture
with respect to the Notes with all rights, powers and obligations as set forth in the Indenture.

ARTICLE II

MISCELLANEOUS

          1. Ratification of Indenture; Supplemental Indentures Part of Indenture. Except as
expressly amended hereby, the Indenture is in all respects ratified and confirmed and all the
terms, conditions and provisions thereof shall remain in full force and effect. This Supplemental
Indenture shall form a part of the Indenture for all purposes, and every Holder of Notes heretofore
or hereafter authenticated and delivered shall be bound hereby.

          2. Governing Law. THIS SUPPLEMENTAL INDENTURE SHALL BE GOVERNED BY, AND CONSTRUED IN
ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK.

          3. Concerning the Trustee. The recitals contained herein shall be taken as statements
of the Company and the New Trustee assumes no responsibility for their correctness. The New
Trustee assumes no duties, responsibilities or liabilities by reason of this Supplemental Indenture
other than as set forth in this Supplemental Indenture and the Indenture. In addition, the New
Trustee makes no representation as to the validity or sufficiency of this Supplemental Indenture.

          4. Defined Terms. Unless otherwise defined herein, terms used herein shall have the
meanings set forth in the Indenture.

 

 

          5. Separability. In case any provision in this Supplemental Indenture shall for any
reason be held to be invalid, illegal or unenforceable in any respect, the validity, legality and
enforceability of the remaining provisions of this Supplemental Indenture shall not in any way be
affected or impaired thereby.

          6. Counterparts. This Supplemental Indenture may be executed and delivered in any
number of counterparts, each of which when so executed and delivered shall be deemed to be an
original, and all such counterparts shall together constitute but one and the same instrument.

          7. Effect of Headings. The Section headings herein are for convenience only and shall
not effect the construction thereof.

          IN WITNESS WHEREOF, the parties hereto have caused this First Supplemental Indenture to be
duly executed as of the date first above written.

	 	 	 	 	 
	 	COVENTRY HEALTH CARE, INC.

 	 
	 	by:  	
 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 

	 	 	 	 	 
	 	UNION BANK OF CALIFORNIA, N.A., as Trustee

 	 
	 	by:  	
 	 
	 	 	Name:  	 	 
	 	 	Title:exv10w39

 

EXHIBIT 10.39

PROMISSORY NOTE

$100,000

May 20, 2002

     GIL VAN BOKKELEN, President and CEO of Advanced Biotherapeutics, Inc. (the “Borrower”), FOR
VALUE RECEIVED, hereby promises to pay to the order of ADVANCED BIOTHERAPEUTICS, INC. (the
“Lender”) at the offices of Advanced Biotherapeutics, Inc., 3201 Carnegie Avenue, Cleveland, Ohio
44115-2634, on the earlier to occur of (a) May 20, 2007, or (b) demand by the Lender, the principal
sum of ONE HUNDRED THOUSAND DOLLARS ($100,000), or if less, the aggregate unpaid principal amount,
in lawful money of the United States of America and in immediately available funds.

     The Borrower promises also to pay interest on the unpaid principal amount hereof in like
money, which interest shall accrue, for the account of the Lender from the date hereof until such
principal amount is paid in full, at a rate per annum equal to four and ninety-nine one hundredths
percent (4.99%).

     The Borrower hereby waives presentment, protest or notice of any kind in connection with this
Promissory Note.

     This Promissory Note shall be construed in accordance with and be governed by the law of the
State of Delaware, without giving effect to principles of conflicts of law.

BORROWER:

 

/s/ Gil Van Bokkelen

 
Gil Van Bokkelen

May 20, 2002

 
Dateexv10w1

 

Exhibit 10.1

August 14, 2007

Mr. David R. Bethune

574 Smith Road

Frederickburg, TX 78624

     Re: Executive Chairman

Dear Mr. Bethune:

     We are pleased to extend an employment offer to you on behalf of Zila, Inc. (the “Company”) on
the following terms:

     1. Title. Your title will be Executive Chairman.

     2. Start Date. Your employment with the Company will begin as of August 1, 2007.

     3. Reporting Structure. You will report to the Board of Directors of the Company.

     4. Responsibilities. Your responsibilities will be consistent with the Executive Chairman
position.

     5. Base Salary. Your initial base salary will be paid at the rate of two hundred fifty-five
thousand dollars ($255,000.00) per year, less applicable withholdings as may be required by law, in
accordance with the Company’s regular payroll practices (currently bi-weekly).

     6. Stock Options. Subject to the approval of the Company’s Board of Directors, you will
receive the following stock option grants to purchase the Company’s common stock under the Zila,
Inc. 1997 Stock Option Award Plan, as amended and restated on September 30, 2004 (the “Stock Option
Plan”), or such amended or restated stock option plan as may then be in effect: A total of 75,000
options vesting in four equal quarterly installments (i.e., 18,750 options shall vest on each of
November 1, 2007, February 1, 2008, May 1, 2008 and August 1, 2008). You will also be eligible for
additional stock option grants based on individual performance and/or as may be commensurate with
grants to other executive-level employees. All stock option grants shall be priced as of the date
of grant and shall be governed in all respects by the Stock Option Plan or such amended or restated
stock option plan as may then be in effect.

     7. Restricted Stock. Subject to the approval of the Company’s Board of Directors, you will be
granted 100,000 shares of restricted stock. The restrictions on the shares will be

 

 

Mr. David R. Bethune

August 14, 2007

Page 2

removed in equal amounts on each of November 1, 2007, February 1, 2008, May 1, 2008 and August 1,
2008, respectively.

     8. Special Grant of Stock Options. As a reward for your service as Chairman of the Board of
Directors of the Company, and subject to the approval of the Company’s Board of Directors, you will
receive a one-time grant of 75,000 options to purchase the Company’s common stock, all of which
shall be vested on the date of the grant. The stock options granted under this item shall be
priced at the closing price of the Company’s common stock as of the grant date and shall be
governed in all respects by the Stock Option Plan or such amended or restated stock option plan as
may then be in effect.

     9. Term. The term of this Agreement shall end on the earlier of your departure from the Zila
Board of Directors or July 31, 2008. If your employment is involuntarily terminated prior to July
31, 2008, (1) the unpaid balance of your base salary will be paid immediately; (ii) all stock
options granted prior to termination of your employment shall be deemed immediately vested and
exercisable according to their terms; and (ii) all restrictions applicable to any restricted stock
awarded prior to such termination shall be deemed immediately lifted.

     10. Cooperation in Dispute Resolution. During your employment and thereafter (including
following termination of your employment for any reason), you will make yourself reasonably
available to consult with the Company or any of its affiliated companies with regard to any
potential or actual dispute the Company or any of its affiliated companies may have with any third
party concerning matters about which you have personal knowledge, and to testify about any such
matter should such testimony be required, so long as doing so does not unreasonably interfere with
your then-current professional activities.

     11. Applicable Law. You hereby consent to application of Arizona law to this Agreement
without regard to choice-of-law or conflict-of-law rules.

     12. Severability. In the event that any provision or portion of this Agreement shall be
determined to be invalid or unenforceable for any reason, in whole or in part, the remaining
provisions of this Agreement shall remain in full force and effect to the fullest extent permitted
by law.

     13. Other Agreements. Like all Company employees, you may in the future be required, in the
Company’s reasonable discretion, to execute agreements relating to other Company policies or
substantive matters.

 

 

Mr. David R. Bethune

August 14, 2007

Page 3

     This offer is made pursuant to the authority unanimously approved by the Board of Directors of
the Company at a meeting duly convened for that purpose. If you wish to accept this offer, please
sign where indicated below and return this Agreement.

	 	 	 	 	 	 	 
	 	 	Sincerely,	 	 
	 
	 	 	 	 	 	 
	 	 	Zila, Inc.	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ Gary V. Klinefelter
 

Gary V. Klinefelter, Secretary
	 	 

Statement of Acceptance:

     I have read the foregoing and agree to accept employment with the Company on the terms stated
in this Agreement.

	 	 	 	 	 
	Dated: August 16, 2007

	 	/s/ David R. Bethune
 

David R. Bethune

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00128-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00128-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00128-of-00352.parquet"}]]